Cardiac biomarkers and clinical scores for risk stratification in elderly patients with non-high-risk pulmonary embolism.

Vuilleumier, N; Limacher, A; Méan, M; Choffat, J; Lescuyer, P; Bounameaux, H; Aujesky, D; Righini, M (2015). Cardiac biomarkers and clinical scores for risk stratification in elderly patients with non-high-risk pulmonary embolism. Journal of internal medicine, 277(6), pp. 707-716. Blackwell Scientific Publications 10.1111/joim.12316

[img] Text
Vuilleumier JInternMed 2015.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (154kB) | Request a copy

OBJECTIVE To determine the prognostic accuracy of cardiac biomarkers alone and in combination with clinical scores in elderly patients with non-high-risk pulmonary embolism (PE). DESIGN Ancillary analysis of a Swiss multicentre prospective cohort study. SUBJECTS A total of 230 patients aged ≥65 years with non-high-risk PE. MAIN OUTCOME MEASURES The study end-point was a composite of PE-related complications, defined as PE-related death, recurrent venous thromboembolism or major bleeding during a follow-up of 30 days. The prognostic accuracy of the Pulmonary Embolism Severity Index (PESI), the Geneva Prognostic Score (GPS), the precursor of brain natriuretic peptide (NT-proBNP) and high-sensitivity cardiac troponin T (hs-cTnT) was determined using sensitivity, specificity, predictive values, receiver operating characteristic (ROC) curve analysis, logistic regression and reclassification statistics. RESULTS The overall complication rate during follow-up was 8.7%. hs-cTnT achieved the highest prognostic accuracy [area under the ROC curve: 0.75, 95% confidence interval (CI): 0.63-0.86, P < 0.001). At the predefined cut-off values, the negative predictive values of the biomarkers were above 95%. For levels above the cut-off, the risk of complications increased fivefold for hs-cTnT [odds ratio (OR): 5.22, 95% CI: 1.49-18.25] and 14-fold for NT-proBNP (OR: 14.21, 95% CI: 1.73-116.93) after adjustment for both clinical scores and renal function. Reclassification statistics indicated that adding hs-cTnT to the GPS or the PESI significantly improved the prognostic accuracy of both clinical scores. CONCLUSION In elderly patients with nonmassive PE, NT-proBNP or hs-cTnT could be an adequate alternative to clinical scores for identifying low-risk individuals suitable for outpatient management.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of General Internal Medicine (DAIM) > Clinic of General Internal Medicine
04 Faculty of Medicine > Pre-clinic Human Medicine > CTU Bern

UniBE Contributor:

Limacher, Andreas; Méan Pascual, Marie and Aujesky, Drahomir

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0954-6820

Publisher:

Blackwell Scientific Publications

Language:

English

Submitter:

Doris Kopp Heim

Date Deposited:

03 Feb 2015 14:19

Last Modified:

14 Sep 2017 09:19

Publisher DOI:

10.1111/joim.12316

PubMed ID:

25285747

Uncontrolled Keywords:

NT-proBNP, aged, biochemical markers, prognosis, pulmonary embolism, troponin

BORIS DOI:

10.7892/boris.62337

URI:

https://boris.unibe.ch/id/eprint/62337

Actions (login required)

Edit item Edit item
Provide Feedback